This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $56,516.10, is for the delivery of XOLAIR 300 MG/2 ML SYRINGE 2ML and has an ultimate completion date of October 16, 2024.
DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The current award is one such delivery order under this larger IDC vehicle, which solidifies DMS Pharmaceutical Group's position as a crucial supplier in the federal pharmaceutical supply chain.
Generated 12/24/24, 9:31 AM